Time toxicity associated with treatment of metastatic or unresectable gastro-oesophageal cancers in the second-line setting
Supportive Care in Cancer · 2026-02 · 34 (2)
DOI: 10.1007/s00520-026-10359-w ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Supportive Care in Cancer, online erschienen am 29.01.2026. Verfasst von Rebecca Han Nguyen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Liverpool Cancer Therapy Centre, Liverpool Hospital, Cnr Elizabeth & Goulburn Street, Liverpool, NSW, Australia. Rebe…. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Stomach Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of New South Wales.
Abstract (Originalsprache)
Purpose
Patients with metastatic or unresectable gastro-oesophageal cancers (mGECs) have poor prognoses and often face high symptom burdens and rates of disease-related complications. Second-line treatments offer modest survival gains, which need to be balanced with treatment toxicities. Time toxicity (TT) is increasingly recognised as a hidden toxicity of cancer therapy, and thus, this study aimed to quantify TT to patients undergoing second-line treatment for mGECs.
Methods
This was a retrospective cohort study across three major hospitals in Sydney, Australia. Records were reviewed for all patients who received second-line systemic therapy for mGECs over 10 years. TT was defined as the number of days patients spent physically interacting with the healthcare system.
Results
Eighty patients were identified, with the majority male (83%) and a median age of 64 years. The median time on second-line treatment was 2.4 months, and the median overall survival from the commencement of second-line treatment was 5.8 months. Patients spent a median 25% of days in physical contact with healthcare, of which 20% were planned encounters (e.g. clinic appointments, scheduled investigations, and treatment days). TT was lower in patients who remained on second-line treatment for more than 2 months versus those on treatment less than 2 months (29% vs. 23%, p < 0.001). One in eight patients died within 30 days of receiving second-line treatment.
Conclusion
Patients on second-line treatment for mGEC spent 1 in 4 days in contact with healthcare, and 30-day mortality following systemic treatment was high. These findings may guide decisions and informed consent surrounding second-line treatment in mGECs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Liverpool Cancer Therapy Centre, Liverpool Hospital, Cnr Elizabeth & Goulburn Street, Liverpool, NSW, Australia. RebeccaHan.Nguyen@health.nsw.gov.au.
- School of Clinical Medicine, South Western Sydney Clinical Campuses, UNSW Sydney, Sydney, NSW, Australia. RebeccaHan.Nguyen@health.nsw.gov.au.
- Department of Medical Oncology, Liverpool Cancer Therapy Centre, Liverpool Hospital, Cnr Elizabeth & Goulburn Street, Liverpool, NSW, Australia.
- School of Medicine, Western Sydney University, Sydney, NSW, Australia.
- Department of Medical Oncology, Macarthur Cancer Therapy Centre, Campbelltown Hospital, Campbelltown, NSW, Australia.
- Department of Medical Oncology, Bankstown Cancer Centre, Bankstown-Lidcombe Hospital, Bankstown, NSW, Australia.
Förderung
- University of New South Wales
Zitieren
APA
Nguyen, R. H., Tang, J., Nindra, U., Roohullah, A., Yoon, R., Tognela, A., Lim, S. H., Asghari, R., Chua, W., & Ng, W. (2026). Time toxicity associated with treatment of metastatic or unresectable gastro-oesophageal cancers in the second-line setting. Supportive Care in Cancer, 34(2). https://doi.org/10.1007/s00520-026-10359-w
Vancouver
Nguyen RH, Tang J, Nindra U, Roohullah A, Yoon R, Tognela A, et al. Time toxicity associated with treatment of metastatic or unresectable gastro-oesophageal cancers in the second-line setting. Supportive Care in Cancer. 2026;34(2). doi:10.1007/s00520-026-10359-w
BibTeX
@article{Nguyen2026,
author = {Nguyen, Rebecca Han and Tang, Joanne and Nindra, Udit and Roohullah, Aflah and Yoon, Robert and Tognela, Annette and Lim, Stephanie Hui-Su and Asghari, Ray and Chua, Wei and Ng, Weng},
title = {Time toxicity associated with treatment of metastatic or unresectable gastro-oesophageal cancers in the second-line setting},
journal = {Supportive Care in Cancer},
year = {2026},
volume = {34},
number = {2},
doi = {10.1007/s00520-026-10359-w}
}
EUVIMED